Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University’s Medical Sciences Business Development & Partnering team reflect on 2018 and look forward to 2019

The Business Development & Partnering team standing together surrounded by festive Christmas decoration

2018 was a landmark year for the Divisional Business Development and Partnering Team. In addition to strengthening our research alliances with UCB, Novo Nordisk, Celgene, Pfizer and Bayer, we also saw some important strategic developments. We were delighted to welcome Novo Nordisk to Oxford in the summer, with the opening of the Novo Nordisk Oxford Research Centre based on the Old Road Campus which will strengthen our research partnership. The summer also saw the opening of the BioEscalator, a hub for new and developing life science innovations.

We were thrilled to learn that Innovate UK and industry are to invest more than £17.5 million in the University of Oxford to develop artificial intelligence (AI) healthcare applications. Funding will be provided through the Government’s Industrial Strategy Challenge Fund by as part of a £50 million investment to establish a network of digital pathology, imaging and AI centres, to drive innovation in the use of AI for improved diagnosis and delivery of precision treatments.

We have continued to deliver a range of events to engage our research community with industry, including the 2018 AIMday in Biomedical Imaging which was a huge success and we hope to repeat this in 2019 with a new AIMday in Advanced Therapies and Regenerative Medicine.

More recently, the Oxford MIT Healthcare Technologies of the Future Conference saw the University of Oxford and MIT come together to strengthen and share our industry networks and highlight some of our spin outs.

We are delighted to have developed, delivered and supported so many alliances, collaborations, opportunities and events in 2018 and look forward to a successful and fruitful 2019.

Find out more about the Business Development Team

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

AIMday in Women's Health - registration for academics now open

Events Innovation

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.